RxDoctor Payments Data

Ryan Cunnane, MD

Clinical Cardiac Electrophysiology · Ann Arbor, MINPI 1841469517

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (37.4%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Medtronic at 50.8% of the total. Reporting peaked in 2024 at $42,258 and has fallen 57.7% since, to $17,885 in 2025. Among clinical cardiac electrophysiology clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$218,171in general payments, 2019–2025

Across 467 payments — averaging $467.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$111K
  • Boston Scientific$51K
  • Abbott$31K
  • Biotronik Inc.$22K
  • Philips North America LLC$2K
  • Impulse Dynamics (USA) Inc.$599
  • plus $439 from 4 others
$11,834in research payments, 2019–2025

Across 16 payments — averaging $739.59 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$12K

What the payments were for

  • Consulting fees$69,13032%
  • Speaking & faculty fees$81,63437%
  • Travel & lodging$49,55723%
  • Food & beverage$17,8498%
  • Education$10%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$218,171 in reported general payments places this provider in the 95th percentile of 105 clinical cardiac electrophysiology providers in Michigan.

See all clinical cardiac electrophysiology providers in Michigan

Medicare billing

Part B allowed, 2024
$69,613
Medicare patients
518
Services billed
688

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban112$142,955
XareltoRivaroxaban14$13,574
Dofetilide31$8,101
Amiodarone Hcl64$1,766
Metoprolol Succinate56$1,387
SotalolSotalol Hcl40$733
Flecainide Acetate11$699
Warfarin Sodium19$546
Diltiazem 24hr Er (Cd)Diltiazem Hcl18$432
Metoprolol Tartrate22$379

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Ann Arbor

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →